These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17556670)

  • 21. Cyclic nucleotide signalling compartmentation by PDEs in cultured vascular smooth muscle cells.
    Zhang L; Bouadjel K; Manoury B; Vandecasteele G; Fischmeister R; Leblais V
    Br J Pharmacol; 2019 Jun; 176(11):1780-1792. PubMed ID: 30825186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
    Kokkonen K; Kass DA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.
    Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F
    Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells.
    Kim NN; Huang Y; Moreland RB; Kwak SS; Goldstein I; Traish A
    Mol Cell Biol Res Commun; 2000 Jul; 4(1):10-4. PubMed ID: 11152621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
    Dunkern TR; Hatzelmann A
    Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
    Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
    Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel.
    Lugnier C; Keravis T; Eckly-Michel A
    J Physiol Pharmacol; 1999 Dec; 50(4):639-52. PubMed ID: 10639014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
    Bellamy TC; Garthwaite J
    Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in phosphodiesterase activity in the developing rat submandibular gland.
    Tanaka S; Shimooka S; Shimomura H
    Arch Oral Biol; 2002 Aug; 47(8):567-76. PubMed ID: 12221013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells.
    Hartzell HC; Fischmeister R
    Nature; 1986 Sep 18-24; 323(6085):273-5. PubMed ID: 2429189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets.
    Kleppe R; Jonassen I; Døskeland SO; Selheim F
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of intracellular cyclic GMP levels in olfactory sensory neurons.
    Moon C; Simpson PJ; Tu Y; Cho H; Ronnett GV
    J Neurochem; 2005 Oct; 95(1):200-9. PubMed ID: 16181424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of myocardial calcium channels by cyclic AMP metabolism.
    Hove-Madsen L; Méry PF; Jurevicius J; Skeberdis AV; Fischmeister R
    Basic Res Cardiol; 1996; 91 Suppl 2():1-8. PubMed ID: 8957537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility.
    Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):665-70. PubMed ID: 23649864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesterases in the central nervous system.
    Kleppisch T
    Handb Exp Pharmacol; 2009; (191):71-92. PubMed ID: 19089326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells.
    Yao J; Hiramatsu N; Zhu Y; Morioka T; Takeda M; Oite T; Kitamura M
    J Am Soc Nephrol; 2005 Jan; 16(1):58-67. PubMed ID: 15537869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cGMP-cAMP interplay in cardiac myocytes: a local affair with far-reaching consequences for heart function.
    Stangherlin A; Zaccolo M
    Biochem Soc Trans; 2012 Feb; 40(1):11-4. PubMed ID: 22260658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The phototransduction cascade in the isolated chick pineal gland revisited.
    Holthues H; Vollrath L
    Brain Res; 2004 Mar; 999(2):175-80. PubMed ID: 14759496
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes.
    Stangherlin A; Gesellchen F; Zoccarato A; Terrin A; Fields LA; Berrera M; Surdo NC; Craig MA; Smith G; Hamilton G; Zaccolo M
    Circ Res; 2011 Apr; 108(8):929-39. PubMed ID: 21330599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.